[Two-pore-domain potassium channels and molecular mechanisms underlying migraine].

Canaux potassiques à deux domaines P (K2P) et migraine.

Journal

Biologie aujourd'hui
ISSN: 2105-0686
Titre abrégé: Biol Aujourdhui
Pays: France
ID NLM: 101544020

Informations de publication

Date de publication:
2019
Historique:
received: 04 06 2019
entrez: 6 7 2019
pubmed: 6 7 2019
medline: 16 1 2020
Statut: ppublish

Résumé

Migraine is a common, disabling neurological disorder with genetic, environmental and hormonal components and a prevalence estimated at ∼15%. Migraine episodes are notably related, among several factors, to electric hyperexcitability in sensory neurons. Their electrical activity is controlled by ion channels that generate current, specifically by the two-pore-domain potassium, K2P, channels, which inhibit electrical activity. Mutation in the gene encoding TRESK, a K2P channel, causes the formation of TRESK-MT1, the expected non-functional C-terminal truncated TRESK channel, and an additional unexpected protein, TRESK-MT2, which corresponds to a non-functional N-terminal truncated TRESK channel, through a mechanism called frameshift mutation-induced Alternative Translation Initiation (fsATI). TRESK-MT1 is inactive but TRESK-M2 targets two other ion channels, TREK1 and TREK2, inducing a great stimulation of the neuronal electrical activity that may cause migraines. These findings identify TREK1 and TREK2 as potential molecular targets for migraine treatment and suggest that fsATI should be considered as a distinct class of mutations.

Identifiants

pubmed: 31274103
doi: 10.1051/jbio/2019020
pii: jbio190020
doi:

Substances chimiques

KCNK18 protein, human 0
Potassium Channels 0
Potassium Channels, Tandem Pore Domain 0

Types de publication

Journal Article Review

Langues

fre

Sous-ensembles de citation

IM

Pagination

51-57

Informations de copyright

© Société de Biologie, 2019.

Auteurs

Perrine Royal (P)

Université Côte d'Azur, CNRS, INSERM, Institut de Biologie Valrose, Parc Valrose, 06108 Nice, France - Laboratories of Excellence, Ion Channel Science and Therapeutics, Nice, France.

Pablo Ávalos Prado (P)

Université Côte d'Azur, CNRS, INSERM, Institut de Biologie Valrose, Parc Valrose, 06108 Nice, France - Laboratories of Excellence, Ion Channel Science and Therapeutics, Nice, France.

Brigitte Wdziekonski (B)

Université Côte d'Azur, CNRS, INSERM, Institut de Biologie Valrose, Parc Valrose, 06108 Nice, France - Laboratories of Excellence, Ion Channel Science and Therapeutics, Nice, France.

Guillaume Sandoz (G)

Université Côte d'Azur, CNRS, INSERM, Institut de Biologie Valrose, Parc Valrose, 06108 Nice, France - Laboratories of Excellence, Ion Channel Science and Therapeutics, Nice, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH